Webinars and Sponsored Roundtables — Register Now

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.

Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice

Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Marketplace Directory

Gold nanoshells, 9/14

September 2014—NanoComposix unveiled its BioReady Gold line of products that include new surface chemistries for covalent attachment to gold nanoparticles and gold nanoshells.

Automated molecular diagnostics technology, 9/14

September 2014—Rheonix displayed its Chemical and Reagent Device, CARD, and EncompassMDx molecular testing platform at AACC. The Rheonix CARD is a disposable cartridge the size of a credit card that runs multiple samples simultaneously without user intervention.

Roche products and acquisitions, 9/14

September 2014—New products featured by Roche this year include analyzers, an automated workflow series, and assays. The Cobas u 601 urine analyzer is a fully automated solution for urine strip testing in mid- to high-volume labs that delivers high-quality results through reagent test strips. This analyzer is not available for sale in the U.S.; a 510(k) submission is pending.

Integrated diagnostic solutions, 9/14

September 2014—Currently in development from Abbott is the Iridica platform, targeted for release in CE-marked European countries within 12 months, to test for and identify hundreds of bacteria and candida, fungi, and viruses from a direct patient specimen.

Portable blood test device, 9/14

September 2014—Atomo Diagnostics introduced the AtomoRapid all-in-one blood test. It can accommodate test strips for a variety of conditions, from celiac disease and allergies to infectious diseases, such as malaria and HIV.

Laboratory solutions, 9/14

September 2014—Beckman Coulter Diagnostics showcased five laboratory solutions in its booth, which was themed “New Laboratory Challenges Require New Thinking”: the Power Express automation solution consolidates immunoassay, hematology, and coagulation; the DxH Connected Workcell offers labs workflow management while delivering comprehensive and accurate patient results; the latest addition of the IRIS International urinalysis portfolio; the Remisol Advance enterprise data management system; and its immunoassay diagnostic testing menu, which includes AccuTnI+3 troponin I in the cardiac panel, the Prostate Health Index (phi) as part of the men’s health panel, and a complete reproductive panel.

Quality by Design-based program, 9/14

September 2014—Multisorb’s QbD-based Calculations through Operations program provides an effective and efficient solution for ensuring the chemical and physical stability of IVD devices through their desired shelf life.

Hematology analyzers, 9/14

September 2014—Sysmex America displayed four new products at its booth. The DI-60 Integrated Slide Processing System provides automation of manual WBC differential process in a stand-alone configuration, offering a cell image analyzer for any type of laboratory or budget.

Women’s health care lab, 9/14

September 2014—Medical experts representing Vermillion, a multivariate diagnostics company focused on gynecologic cancers and women’s health, presented on Aspira Labs, its new CLIA-certified reference laboratory. Aspira Labs provides expert diagnostic services, including OVA1 and Longitudinal CA 125 testing, which support clinical decision-making and personalized treatment plans.

LIS-LIMS process management software suite, 9/14

September 2014—UniConnect announced the release of its PrecisionMDx System for molecular laboratories. The system has been developed for laboratory professionals seeking a focused solution for CAP- and CLIA-certified molecular laboratory operations, and the software platform is ideal for MDx, CDx, and PGx pursuits.